Acasti Pharma, Inc. News Headlines

ACST 
$0.4716
*  
0.0182
3.72%
Get ACST Alerts
*Delayed - data as of Mar. 27, 2015  -  Find a broker to begin trading ACST now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACST After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By





CaPre Phase 2 trial hits all endpoints
9/30/2014 7:46:00 AM - Seeking Alpha




















Neptune Erecting A Moat In Omega-3; Shares Undervalued
1/21/2014 11:46:00 AM - Seeking Alpha


While Amarin Continues To Go Rancid, Neptune Will Soar
1/11/2014 8:34:00 AM - Seeking Alpha




Sector Update: Healthcare
12/17/2013 3:02:46 PM - MT Newswires






5 'Red Hot' Biotechs: Chen Lin
7/3/2013 5:38:00 PM - Seeking Alpha


Krill Oil's Omega-3s And CaPre: Brought To You By Acasti
4/3/2013 3:58:00 AM - Seeking Alpha




Amarin: The More You Know The Fishier It Gets
2/27/2013 12:59:00 AM - Seeking Alpha








    • << first
    • < previous
    • 1
    • next >
    • last >>